KIT and acute myeloid leukemia: Consequently, it exhibited anti-proliferative effects against FLT3 ITD AML cells in vitro and in vivo by inducing the degradation of FLT3 ITD and c-KIT, thereby abolishing oncogenic downstream signalling [88].